Fei Fei
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 8
- Cancer-related gene regulation 6
- S100 Proteins and Annexins 5
- RNA Research and Splicing 4
- Epigenetics and DNA Methylation 4
- Oncology 21
- Cancer Cells and Metastasis 8
- Co-authors
- Shiwu Zhang (21 shared papers)Yuwei Li (16 shared papers)Mingqing Zhang (4 shared papers)Chunyuan Li (6 shared papers)Zhengduo Yang (4 shared papers)Jie Qu (5 shared papers)Dan Zhang (3 shared papers)Xinlu Wang (4 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Journal of Cancer (5 papers)Cancer Science (3 papers)Cancer Research (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Fei Fei
72 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 469
- Oncology 476
- Cell Biology 249
- Molecular Biology 975
- Immunology 251
Countries citing papers authored by Fei Fei
This map shows the geographic impact of Fei Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Fei more than expected).
Fields of papers citing papers by Fei Fei
This network shows the impact of papers produced by Fei Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Fei. The network helps show where Fei Fei may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Fei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 140 | |
| 2 | 2015 | 133 | |
| 3 | 2006 | 126 | |
| 4 | 2019 | 101 | |
| 5 | 2010 | 93 | |
| 6 | 2015 | 85 | |
| 7 | 2017 | 83 | |
| 8 | 2014 | 74 | |
| 9 | 2023 | 68 | |
| 10 | 2017 | 58 | |
| 11 | 2018 | 49 | |
| 12 | 2014 | 47 | |
| 13 | 2018 | 46 | |
| 14 | 2019 | 36 | |
| 15 | 2019 | 35 | |
| 16 | 2014 | 33 | |
| 17 | 2019 | 33 | |
| 18 | 2018 | 30 | |
| 19 | 2018 | 30 | |
| 20 | 2020 | 29 |
About Fei Fei
Fei Fei is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Pathology and Forensic Medicine, having authored 78 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), RNA modifications and cancer (8 papers), Cancer-related gene regulation (6 papers), Galectins and Cancer Biology (5 papers), S100 Proteins and Annexins (5 papers), RNA Research and Splicing (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (469 citations), Oncology (476 citations), Cell Biology (249 citations), Molecular Biology (975 citations) and Immunology (251 citations). Fei Fei has collaborated with scholars based in China, United States and India. Frequent co-authors include Shiwu Zhang, Yuwei Li, Mingqing Zhang, Chunyuan Li, Zhengduo Yang, Jie Qu, Dan Zhang, Xinlu Wang, Jinliang Xing and Zhi‐Nan Chen. Their work appears in journals such as Frontiers in Oncology, Journal of Cancer, Cancer Science, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.